logo

Seattle Genetics Inc. (SGEN)



Trade SGEN now with
  Date
  Headline
12/2/2019 8:05:08 AM Seattle Genetics, Astellas Pharma Announce Clinical Collaboration Agreement With Merck
11/25/2019 8:08:23 AM Seattle Genetics : Canada Oks ADCETRIS -Chemotherapy In Frontline CD30-Expressing Peripheral T-Cell Lymphoma
11/12/2019 6:27:29 PM Seattle Genetics Submits Arbitration Demand Against Daiichi Sankyo Over Technology Ownership
11/7/2019 8:08:24 AM Seattle Genetics Announces Multiple ADCETRIS Presentations
11/5/2019 8:06:58 AM Seattle Genetics, BeiGene Announce License Agreement For Advanced Preclinical Product Candidate For Treating Cancer
11/4/2019 11:56:59 PM Seattle Genetics Responds To Daiichi Sankyo's Complaint For Declaratory Judgment
10/29/2019 4:07:51 PM Seattle Genetics Q3 Loss Per Share $0.55 Vs Loss $0.42 Last Year
10/21/2019 6:48:17 AM Seattle Genetics Reports Positive Topline Results From HER2CLIMB trial
9/16/2019 8:02:47 AM Seattle Genetics And Astellas: FDA Grants Priority Review For Enfortumab Vedotin BLA
  
 
>